Conditions: 1p/19q Co-deletion; Anaplastic Astrocytoma; Diffuse Astrocytoma; Glioma; IDH1 Gene Mutation; IDH2 Gene Mutation; Oligoastrocytoma; Oligodendroglioma; WHO Grade III Glioma
Interventions: Radiation: IMRT (Intensity-Modulated Radiation Therapy); Radiation: Proton Beam Radiation Therapy; Drug: Temozolomide
Sponsors: NRG Oncology; National Cancer Institute (NCI)
Active, not recruiting